Literature DB >> 2443876

Lack of change in indoleamine metabolism in spinal cord of patients with amyotrophic lateral sclerosis.

K Ohsugi1, K Adachi, M Mukoyama, K Ando.   

Abstract

Indoleamine metabolism was determined by high-performance liquid chromatography with electrochemical detection in the cervical spinal cord of patients with amyotrophic lateral sclerosis (ALS) and controls with non-neurological diseases. The concentrations of 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) were the highest in the ventral horn compared with other regions of the spinal cord both in ALS and controls. There was no significant change in the concentration of 5-HT in any region of the spinal cord between ALS and controls. In addition, the concentration of 5-HIAA in ALS was lower than that in controls, however, no statistical significance was observed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443876     DOI: 10.1016/0304-3940(87)90458-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Effect of fluoxetine on disease progression in a mouse model of ALS.

Authors:  J E Koschnitzky; K A Quinlan; T J Lukas; E Kajtaz; E J Kocevar; W F Mayers; T Siddique; C J Heckman
Journal:  J Neurophysiol       Date:  2014-03-05       Impact factor: 2.714

2.  Serotonergic Dysfunction in Amyotrophic Lateral Sclerosis and Parkinson's Disease: Similar Mechanisms, Dissimilar Outcomes.

Authors:  Yannick Vermeiren; Jana Janssens; Debby Van Dam; Peter P De Deyn
Journal:  Front Neurosci       Date:  2018-03-20       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.